Diazoxide choline extended‐release tablet in people with Prader‐Willi syndrome: results from long‐term open‐label study.

MLA

Miller, Jennifer L., et al. “Diazoxide Choline Extended‐release Tablet in People with Prader‐Willi Syndrome: Results from Long‐term Open‐label Study.” Obesity (19307381), vol. 32, no. 2, Feb. 2024, pp. 252–61. EBSCOhost, https://doi.org/10.1002/oby.23928.

APA

Miller, J. L., Gevers, E., Bridges, N., Yanovski, J. A., Salehi, P., Obrynba, K. S., Felner, E. I., Bird, L. M., Shoemaker, A. H., Angulo, M., Butler, M. G., Stevenson, D., Goldstone, A. P., Wilding, J., Lah, M., Shaikh, M. G., Littlejohn, E., Abuzzahab, M. J., Fleischman, A., & Hirano, P. (2024). Diazoxide choline extended‐release tablet in people with Prader‐Willi syndrome: results from long‐term open‐label study. Obesity (19307381), 32(2), 252–261. https://doi.org/10.1002/oby.23928

Chicago

Miller, Jennifer L., Evelien Gevers, Nicola Bridges, Jack A. Yanovski, Parisa Salehi, Kathryn S. Obrynba, Eric I. Felner, et al. 2024. “Diazoxide Choline Extended‐release Tablet in People with Prader‐Willi Syndrome: Results from Long‐term Open‐label Study.” Obesity (19307381) 32 (2): 252–61. doi:10.1002/oby.23928.